Back to today’s briefing

Story perspectives

New Stem Cell Treatment Halts Insulin for 10 Diabetics

6/24/2025

38 5

Summary

Diabetes Breakthrough Treatment

A groundbreaking clinical trial with 12 type 1 diabetes patients revealed that after receiving the stem cell treatment zimislecel, ten participants were able to stop insulin therapy entirely after just a year. Developed by Vertex Pharmaceuticals, this innovative approach could transform diabetes care, pending further research and FDA approval. The findings were shared in the New England Journal of Medicine.

Summary

Oral Drug Innovation

A groundbreaking oral drug, designed as a ?2 agonist, offers hope for those battling type 2 diabetes and obesity, sidestepping the unwanted side effects of existing GLP-1 injections. Early trials reveal its potential to enhance metabolism and regulate blood sugar, with Phase II studies on the horizon to validate its impact on human health. This exciting research was featured in Cell.

1 of 2

Diabetes Breakthrough Treatment

A groundbreaking clinical trial with 12 type 1 diabetes patients revealed that after receiving the stem cell treatment zimislecel, ten participants were able to stop insulin therapy entirely after just a year. Developed by Vertex Pharmaceuticals, this innovative approach could transform diabetes care, pending further research and FDA approval. The findings were shared in the New England Journal of Medicine.

1 / 2